![Doug Gentilcore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Doug Gentilcore formerly worked at Jubilant DraxImage, Inc., as Vice President-Global Sales & Business Operations, Y-mAbs Therapeutics, Inc., as Senior VP & Head-Danyelza Business Unit in 2025, and ARTMS, Inc., as Chief Commercial Officer.
Mr. Gentilcore received his undergraduate degree from Randolph-Macon College.
Anciens postes connus de Doug Gentilcore
| Sociétés | Poste | Fin |
|---|---|---|
| YMAS THER | Corporate Officer/Principal | 16/09/2025 |
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes radiopharmaceuticals products for heart, thyroid, lung & bone disease | Sales & Marketing | - |
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | - |
Formation de Doug Gentilcore
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Randolph-Macon College
 Randolph-Macon College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes radiopharmaceuticals products for heart, thyroid, lung & bone disease | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
